Form 4: Guardant Health Executive Exercises Stock Options

AmirAli Talasaz, Co-Chief Executive Officer of Guardant Health, Inc., exercised stock options to acquire 283,830 shares of common stock at a price of $4.18 per share.

Summary

• On May 2, 2024, AmirAli Talasaz, Co-Chief Executive Officer of Guardant Health, Inc., exercised stock options.
• This transaction resulted in the acquisition of 283,830 shares of common stock at a price of $4.18 per share.
• Following the transaction, Talasaz directly owns 2,193,127 shares of Guardant Health, Inc.
• The stock options were granted with vesting in equal monthly installments over 48 months commencing on April 23, 2017, and expire on July 14, 2027.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock option exercise, which is a neutral event. It doesn't inherently indicate positive or negative sentiment.

Positives

• The exercise of stock options by a high-ranking executive could be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

Executive stock option exercises are a common practice in publicly traded companies, often used as a form of compensation and incentive for key personnel. The exercise of options can be influenced by factors such as the company's stock price, vesting schedules, and the executive's personal financial planning.

Stakeholder Impact

• The transaction may have a minor impact on shareholders due to the increase in the number of outstanding shares.

Key Dates